Benzoes?ure, 6-(7-(5-Ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-me-thyl-2H-pyran-2-yl)tetrahydro-3-methyl-2-furanyl)-4-hydroxy-3,5-dimethyl-6-oxononyl)-2-hydroxy-3-methyl, Mononatriumsalz, (2R-(2alpha(2S*(3R*,4S*,5S*,7R*),3S*,5S*
|
|
- CAS-Nr.
- 25999-20-6
- Bezeichnung:
- Benzoes?ure, 6-(7-(5-Ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-me-thyl-2H-pyran-2-yl)tetrahydro-3-methyl-2-furanyl)-4-hydroxy-3,5-dimethyl-6-oxononyl)-2-hydroxy-3-methyl, Mononatriumsalz, (2R-(2alpha(2S*(3R*,4S*,5S*,7R*),3S*,5S*
- Englisch Name:
- LASALOCID A SODIUM SALT
- Synonyma:
- mt2007;AVATEC;BOVATEC;ro2-2985;Nsc243046;Avatec sodium;lasalocidsodium;sodiumlasalocid;sodiumlasalocida;LasalocidAsodium
- CBNumber:
- CB2430382
- Summenformel:
- C34H53NaO8
- Molgewicht:
- 612.77
- MOL-Datei:
- 25999-20-6.mol
|
Benzoes?ure, 6-(7-(5-Ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-me-thyl-2H-pyran-2-yl)tetrahydro-3-methyl-2-furanyl)-4-hydroxy-3,5-dimethyl-6-oxononyl)-2-hydroxy-3-methyl, Mononatriumsalz, (2R-(2alpha(2S*(3R*,4S*,5S*,7R*),3S*,5S* Eigenschaften
- Schmelzpunkt:
- 180 °C (dec.)(lit.)
- Flammpunkt:
- 6 °C
- storage temp.
- 0-6°C
- L?slichkeit
- DMSO:100.0(Max Conc. mg/mL);163.19(Max Conc. mM)
- Aggregatzustand
- Solid
- Farbe
- Off-White to Light Beige
- Stabilit?t:
- Hygroscopic
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
Bildanzeige (GHS) |
|
Alarmwort |
Achtung |
Gefahrenhinweise |
Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
H301 |
Giftig bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 3 |
Achtung |
src="/GHS06.jpg" width="20" height="20" /> |
P264, P270, P301+P310, P321, P330,P405, P501 |
|
Sicherheit |
P264 |
Nach Gebrauch gründlich waschen. |
P264 |
Nach Gebrauch gründlich waschen. |
P270 |
Bei Gebrauch nicht essen, trinken oder rauchen. |
P301+P310 |
BEI VERSCHLUCKEN: Sofort GIFTINFORMATIONSZENTRUM/Arzt/... (geeignete Stelle für medizinische Notfallversorgung vom Hersteller/Lieferanten anzugeben) anrufen. |
P321 |
Besondere Behandlung |
P330 |
Mund ausspülen. |
P405 |
Unter Verschluss aufbewahren. |
P501 |
Inhalt/Beh?lter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen. |
|
Benzoes?ure, 6-(7-(5-Ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-me-thyl-2H-pyran-2-yl)tetrahydro-3-methyl-2-furanyl)-4-hydroxy-3,5-dimethyl-6-oxononyl)-2-hydroxy-3-methyl, Mononatriumsalz, (2R-(2alpha(2S*(3R*,4S*,5S*,7R*),3S*,5S* Chemische Eigenschaften,Einsatz,Produktion Methoden
R-S?tze Betriebsanweisung:
R25:Giftig beim Verschlucken.
R36:Reizt die Augen.
R20/21/22:Gesundheitssch?dlich beim Einatmen,Verschlucken und Berührung mit der Haut.
R11:Leichtentzündlich.
S-S?tze Betriebsanweisung:
S28:Bei Berührung mit der Haut sofort abwaschen mit viel . . . (vom Hersteller anzugeben).
S45:Bei Unfall oder Unwohlsein sofort Arzt zuziehen (wenn m?glich, dieses Etikett vorzeigen).
S36/37:Bei der Arbeit geeignete Schutzhandschuhe und Schutzkleidung tragen.
S16:Von Zündquellen fernhalten - Nicht rauchen.
Verwenden
Coccidiostat (for poultry).
Benzoes?ure, 6-(7-(5-Ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-me-thyl-2H-pyran-2-yl)tetrahydro-3-methyl-2-furanyl)-4-hydroxy-3,5-dimethyl-6-oxononyl)-2-hydroxy-3-methyl, Mononatriumsalz, (2R-(2alpha(2S*(3R*,4S*,5S*,7R*),3S*,5S* Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Benzoes?ure, 6-(7-(5-Ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-me-thyl-2H-pyran-2-yl)tetrahydro-3-methyl-2-furanyl)-4-hydroxy-3,5-dimethyl-6-oxononyl)-2-hydroxy-3-methyl, Mononatriumsalz, (2R-(2alpha(2S*(3R*,4S*,5S*,7R*),3S*,5S* Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 92)Lieferanten
25999-20-6(Benzoes?ure, 6-(7-(5-Ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-me-thyl-2H-pyran-2-yl)tetrahydro-3-methyl-2-furanyl)-4-hydroxy-3,5-dimethyl-6-oxononyl)-2-hydroxy-3-methyl, Mononatriumsalz, (2R-(2alpha(2S*(3R*,4S*,5S*,7R*),3S*,5S*)Verwandte Suche:
3-Pentadecylphenol
2-[2-(2-Methylpropoxy)ethoxy]ethanol
Benzoes?ure, 6-(7-(5-Ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-me-thyl-2H-pyran-2-yl)tetrahydro-3-methyl-2-furanyl)-4-hydroxy-3,5-dimethyl-6-oxononyl)-2-hydroxy-3-methyl, Mononatriumsalz, (2R-(2alpha(2S*(3R*,4S*,5S*,7R*),3S*,5S*
2-Hydroxy-3-methylbenzoes?ure
[2R-[2α[2S*(3R*,4S*,5S*,7R*)3S*,5S*],5α,6β]]-6-[7-[5-Ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)tetrahydro-3-methyl-2-furyl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-3-methylsalicylsure
Natriumsalicylat
2,3,6-Trimethylphenol
Heptadecylbenzol
Natrium-3-methylsalicylat
- AVATEC
- BOVATEC
- LASALOCID A SODIUM SALT
- 5-dimethyl-6-oxononyl)--yl)tetrahydro-3-methyl-2-furyl)-4-hydroxy-monosodi
- cresoticacid,6-(7-(5-ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-methyl-2h-pyran-2
- lasalocidsodium
- lasalocidsodiumsalt
- mt2007
- ro2-2985
- Lasalocid sodium ((Lasalocid Sodium) :Avatec)
- [2R-2 alpha[2S*(3R*,4S*,5S*,7R*)3S*,5S*,5 alpha,6 beta]]-6-[7-[5-Ethyl-5-(ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2yl)tetrahydro-3-methyl-2-furanyl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methylbenzoic acid monosodium salt
- Avatec sodium
- Benzoic acid, 6-[7-[5-ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)tetrahydro-3-methyl-2-furanyl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methyl-, monosodium salt, [2R-[2.alpha.[2S*(3R*,4S*,5S*,7R*),3S*,5S*],5.alpha.,6.beta.]]-
- Lasalocid A monosodium salt
- Nsc243046
- 6-[(3R,4S,5S,7R)-7-[(2S,3S,5S)-5-Ethyl-5-[(2R,5R,6S)-5-ethyltetrahydro-5-hydroxy-6-Methyl-2H-pyran-2-yl]tetrahydro-3-Methyl-2-furanyl]-4-hydroxy-3,5-diMethyl-6-oxononyl]-2-hydroxy-3-Methylbenzoi
- Lasalocid A sodium salt solution
- Lasalocid A SodiuM Salt (Solution in acetonitrile 02.Mg/2Ml)
- Avatec, Bovatec, Ro 2-2985, X 537A
- Benzoic acid, 6-[7-[5-ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)tetrahydro-3-methyl-2-furanyl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methyl-, monosodium salt, [2R-[2alpha[2S*(3R*,4S*,5S*,7R*),3S*,5S*],5alpha,6beta
- sodiumlasalocid
- sodiumlasalocida
- LASALOCID, SODIUM SALT, TECH., 90%
- LASALOCID A NATRIUMSALZ VETRANAL
- LasalocidAsodium
- Benzoic acid, 6-(3R,4S,5S,7R)-7-(2S,3S,5S)-5-ethyl-5-(2R,5R,6S)-5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yltetrahydro-3-methyl-2-furanyl-4-hydroxy-3,5-dimethyl-6-oxononyl-2-hydroxy-3-methyl-, monosodium salt
- iasalocid A sodium salt
- Benzoesure, 6-(7-(5-Ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)tetrahydro-3-methyl-2-furanyl)-4-hydroxy-3,5-dimethyl-6-oxononyl)-2-hydroxy-3-methyl-, Mononatriumsalz, (2R-(2alpha(2S*(3R*,4S*,5S*,7R*),3S*,5S*)5alpha,6beta))-
- Roche Avatec 15% Type CC
- Lasalocid A solution sodium salt
- Antibiotic X-537A sodium
- Ionophore X-537A sodium
- LASALOCID A SODIUM SALT USP/EP/BP
- Lasalocid A Sodium Salt (Solution in acetonitrile 0.1mg/ml) (>90%)
- Lasalocid A Sodium Salt (>90%)
- Lasalocid,Inhibitor,inhibit,Lasalocid-A,Lasalocid sodium,Bacterial,Antibiotic,Antibiotic X-537A,Autophagy,Ionophore X-537A
- Lasalocid sodium A
- Lasalocid A sodium in Methanol
- C14593000 Lasalocid A sodium
- XA14593000ALLasalocid A sodium 100μg/mLin Ace
- 25999-20-6
- C34H53O8Na
- C34H53NaO8
- Aromatics
- Chiral Reagents
- Heterocycles
- Intermediates & Fine Chemicals
- Pharmaceuticals
- BacteriostaticAnalytical Standards
- LAntibiotics
- Alphabetic
- Antibiotics
- Chemical Structure
- Chromatography
- OthersAnalytical Standards
- Pharmacology Standards
- Principle